Fluorescence in situ hybridization patterns of BCR/ABL1 fusion in chronic myelogenous leukemia at diagnosis

被引:7
|
作者
Poonam, Jain P. [1 ]
Mayur, Parihar [3 ]
Rayaz, Ahmed [2 ]
Aby, Abraham [2 ]
Auro, Vishwabandya [2 ]
Biju, George [2 ]
Vikram, Mathews [2 ]
Alok, Srivastava [2 ]
Vivi, Srivastava M. [1 ]
机构
[1] Christian Med Coll & Hosp, Cytogenet Unit, Vellore 632004, Tamil Nadu, India
[2] Christian Med Coll & Hosp, Dept Hematol, Vellore 632004, Tamil Nadu, India
[3] Tata Med Ctr, Dept Cytogenet, Kolkata, W Bengal, India
关键词
Chronic myelogenous leukemia; BCR/ABL1; fusion; atypical FISH signals; CHRONIC-MYELOID-LEUKEMIA; D-FISH PATTERNS; DERIVATIVE CHROMOSOME-9; VARIANT TRANSLOCATIONS; CYTOGENETIC RESPONSE; GENE REARRANGEMENTS; PERIPHERAL-BLOOD; CLONAL EVOLUTION; CML; DELETIONS;
D O I
10.4103/0377-4929.101742
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Chronic myelogenous leukemia (CML) is characterised by the t(9;22)(q34;q11.2) which results in the formation of the BCR/ABL1 fusion gene. Occasionally, the t(9;22) may be associated with submicroscopic deletions of chromosomes 9 and/or 22 which appear to be associated with a worse prognosis. Three or four-way variant t(9;22) may also occur. All these changes as well as gain of the Philadelphia chromosome which represents disease progression can be detected by fluorescence in situ hybridization (FISH) analysis. FISH analysis at presentation is used to determine the number of cells with BCR/ABL1 fusion and establish whether the patterns are typical or atypical. Response to therapy can then be monitored by serial testing. Patients and Methods: The study group consisted of all patients diagnosed or suspected to have CML who had interphase FISH analysis at presentation on peripheral blood/bone marrow using a commercially available BCR/ABL1 dual colour, dual fusion probe. The study was performed at a tertiary hospital in India between 2004 and 2010. Results: There were 1076 diagnostic samples which were positive for BCR/ABL1 fusion. Typical dual fusion signals (two fusions, one red and one green, 2F1R1G) were seen in 801 cases (74 %). Atypical signal patterns were seen in 275 cases (26%). These were: 1F1R2G (4%), 1F2R1G (2.5%) and 1F1R1G (11%) representing deletions of the derivative 9 involving chromosome 9 sequences, chromosome 22 sequences, or both respectively; 3F1R1G (6.5%) usually representing gain of an additional Philadelphia chromosome and 1F2R2G (1%) representing a three-or four-way variant translocation. More than one signal pattern was seen in 1%. Conclusions: Our findings were similar to the literature with respect to the distribution of signal patterns except that we had a lower number of patients with variant translocations. While each signal pattern is typically associated with a particular abnormality, there can be more than one explanation for each pattern. Hence, metaphase FISH analysis is the "gold standard" for the interpretation of signal patterns.
引用
下载
收藏
页码:347 / 351
页数:5
相关论文
共 50 条
  • [1] Standardization criteria for the detection of BCR/ABL fusion in interphase nuclei of chronic myelogenous leukemia patients by fluorescence in situ hybridization
    Cohen, N
    Novikov, I
    Hardan, I
    Esa, A
    Brok-Simoni, F
    Amariglio, N
    Rechavi, G
    Ben-Bassat, I
    Trakhtenbrot, L
    CANCER GENETICS AND CYTOGENETICS, 2000, 123 (02) : 102 - 108
  • [2] Cytogenetic, fluorescence in situ hybridization, and molecular characterization of chronic myeloid leukemia in chronic phase with four BCR/ABL1 fusion signals: a case report
    Teresa Vargas, Maria
    Angeles Portero, Maria
    Rodriguez, Alicia
    Reyes, Juana
    Fernandez-Novoa, Carmen
    CANCER GENETICS AND CYTOGENETICS, 2009, 195 (01) : 71 - 74
  • [3] Subclonal acquisition of a BCR::ABL1 fusion in a chronic myelomonocytic leukemia
    Benjamin Podvin
    Hélène Guermouche
    Pauline Roynard
    Laure Goursaud
    Céline Berthon
    Mahdi Ouafi
    Elise Fourner
    Nicolas Duployez
    Olivier Nibourel
    Catherine Roche-Lestienne
    Annals of Hematology, 2022, 101 : 2093 - 2095
  • [4] Subclonal acquisition of a BCR::ABL1 fusion in a chronic myelomonocytic leukemia
    Podvin, Benjamin
    Guermouche, Helene
    Roynard, Pauline
    Goursaud, Laure
    Berthon, Celine
    Ouafi, Mahdi
    Fourner, Elise
    Duployez, Nicolas
    Nibourel, Olivier
    Roche-Lestienne, Catherine
    ANNALS OF HEMATOLOGY, 2022, 101 (09) : 2093 - 2095
  • [5] Application of Fluorescent In Situ Hybridization (FISH) to detect BCR/ABL fusion in patients with chronic myelogenous leukemia.
    Quintana, MS
    Rojas-Atencio, A
    Alvarez-Nava, F
    Urdaneta, K
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 227 - 227
  • [6] CLINICAL DETECTION OF BCR-ABL FUSION BY INSITU HYBRIDIZATION IN CHRONIC MYELOGENOUS LEUKEMIA
    AMIEL, A
    YARKONI, S
    FEJGIN, M
    GABER, E
    NAGLER, A
    MANOR, Y
    LISHNER, M
    CANCER GENETICS AND CYTOGENETICS, 1993, 65 (01) : 32 - 34
  • [7] The ABL/BCR fusion gene on chromosome 9 in Ph-negative chronic myelogenous leukemia: A case for vigilance in fluorescence in situ hybridization interpretation
    Hsu, WT
    Preisler, H
    Szego, K
    Sprudzs, R
    Gao, XZ
    CANCER GENETICS AND CYTOGENETICS, 1998, 104 (01) : 57 - 60
  • [8] BCR/ABL1 fluorescence in situ hybridization fusion signals on both copies of chromosome 22 in a Philadelphia-masked chronic myeloid leukemia case: implication for the therapy
    Soriani, Silvia
    Guido, Valentina
    Bertani, Giambattista
    Cesana, Clara
    Motta, Valentina
    De Canal, Gabriella
    De Paoli, Elena
    Veronese, Silvio
    Bonoldi, Emanuela
    Romitti, Lorenza
    HEMATOLOGY REPORTS, 2021, 13 (01)
  • [9] T-LYMPHOCYTES IN CHRONIC MYELOGENOUS LEUKEMIA (CML) - NO EVIDENCE OF THE BCR/ABL FUSION GENE DETECTED BY FLUORESCENCE IN-SITU HYBRIDIZATION IN 14 PATIENTS
    GARICOCHEA, B
    CHASE, A
    LAZARIDOU, A
    GOLDMAN, JM
    LEUKEMIA, 1994, 8 (07) : 1197 - 1201
  • [10] FLUORESCENCE IN SITU HYBRIDIZATION SIGNAL PATTERNS AND INTRACHROMOSOMAL BCR-ABL1 AMPLIFICATION ANALYSIS IN IMATINIB-RESISTANT CHRONIC MYELOGENOUS LEUKEMIA PATIENTS USING TRICOLOR DUAL FUSION PROBE
    Bommannan, K.
    Naseem, S.
    Varma, N.
    Malhotra, P.
    Binota, J.
    Varma, S.
    HAEMATOLOGICA, 2017, 102 : 724 - 724